<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.8" -->
<?xml-stylesheet href="https://onwar.se/lib/exe/css.php?s=feed" type="text/css"?>
<rdf:RDF
    xmlns="http://purl.org/rss/1.0/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
    xmlns:dc="http://purl.org/dc/elements/1.1/">
    <channel rdf:about="https://onwar.se/feed.php">
        <title>Onwards - a_comprehensive_study_report_on_modafinil</title>
        <description></description>
        <link>https://onwar.se/</link>
        <image rdf:resource="https://onwar.se/lib/exe/fetch.php?media=wiki:dokuwiki.svg" />
       <dc:date>2026-10-12T05:53:53+00:00</dc:date>
        <items>
            <rdf:Seq>
                <rdf:li rdf:resource="https://onwar.se/doku.php?id=a_comprehensive_study_report_on_modafinil:mechanisms_uses_and&amp;rev=1791489955&amp;do=diff"/>
            </rdf:Seq>
        </items>
    </channel>
    <image rdf:about="https://onwar.se/lib/exe/fetch.php?media=wiki:dokuwiki.svg">
        <title>Onwards</title>
        <link>https://onwar.se/</link>
        <url>https://onwar.se/lib/exe/fetch.php?media=wiki:dokuwiki.svg</url>
    </image>
    <item rdf:about="https://onwar.se/doku.php?id=a_comprehensive_study_report_on_modafinil:mechanisms_uses_and&amp;rev=1791489955&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2026-10-08T20:05:55+00:00</dc:date>
        <dc:creator>Anonymous (anonymous@undisclosed.example.com)</dc:creator>
        <title>mechanisms_uses_and</title>
        <link>https://onwar.se/doku.php?id=a_comprehensive_study_report_on_modafinil:mechanisms_uses_and&amp;rev=1791489955&amp;do=diff</link>
        <description>(Image: https://images.unsplash.com/photo-1573883430697-4c3479aae6b9?ixid=M3wxMjA3fDB8MXxzZWFyY2h8MTJ8fGJ1eSUyMG1vZGFmaW5pbCUyMG9ubGluZXxlbnwwfHx8fDE3OTE0NTI3NjB8MA\u0026ixlib=rb-4.1.0)
Modafinil is a wakefulness-selling agent that has garnered significant attention in each clinical and non-clinical settings since its approval by the U.S. Food and Drug Administration (FDA) in 1998 for the treatment of narcolepsy and different sleep disorders. This report aims to provide an in-depth evaluation of…</description>
    </item>
</rdf:RDF>
